The data show that glioma specific CD4+ IL-9+ T cells were induced in glioma-bearing mice after treating with SEB and glioma extracts, but not in those treated with either SEB alone or glioma extracts alone. This evidence concerns the gene SETBP1 and central nervous system cancer.